Bartter's syndrome associated with Graves' disease and myasthenia gravis: report of a case.
D000328:Adult; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000494:pharmacology; D001379:Azathioprine / Q000627:therapeutic use; D001477:Bartter Syndrome / Q000188:drug therapy / Q000209:etiology*; D001794:Blood Pressure / Q000187:drug effects; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology*; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000032:analysis; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood; D013960:Thyroid Function Tests
D007136:Immunoglobulins; D000804:Angiotensin II; D000450:Aldosterone; D012083:Renin; D001379:Azathioprine; D011188:Potassium; D009638:Norepinephrine; D007213:Indomethacin